Search results for "Alcohol"

showing 10 items of 1798 documents

Wernicke-Korsakoff syndrome complicated by subacute beriberi neuropathy in an alcoholic patient.

2017

Thiamine (vitamin B1) deficiency is a common condition in alcohol abusers, which can lead to damage of both the peripheral and the central nervous systems. Here we describe the case of an alcoholic patient who presented with acute onset of ataxia, severe weakness of the four limbs, and hypoesthesia and dysesthesia of the distal portion of the upper and lower extremities. The clinical picture also included mental confusion and amnesia. A diagnosis of Wernicke-Korsakoff syndrome was made based on clinical symptoms and brain RMI findings. Electromyography and electroneurography revealed signs of subacute axonal sensory-motor polyneuropathy that were compatible with a rare acute presentation of…

0301 basic medicineMalemedicine.medical_specialtyPediatricsAtaxiaBeriberiWernicke's encephalopathyAlcoholic NeuropathyBeriberi03 medical and health sciences0302 clinical medicinemedicineHumansKorsakoff's syndromeWernicke's encephalopathy030109 nutrition & dieteticsWernicke–Korsakoff syndromeDysesthesiabusiness.industryfood and beveragesGeneral MedicineMiddle Agedmedicine.diseaseSurgeryAlcoholismKorsakoff SyndromeThiamine deficiencyVitamin B ComplexThiamineSurgeryNeurology (clinical)medicine.symptombusinessKorsakoff's syndromePolyneuropathy030217 neurology & neurosurgeryVitamin B1Clinical neurology and neurosurgery
researchProduct

Morphologic variations in the pineal gland of the albino rat after a chronic alcoholisation process.

2018

We studied the effect of alcohol on the pineal gland of 48 male Wistar rats. Animals were divided into control and experimental groups. The experimental group underwent a previous progressive alcoholisation period with ethanol diluted in water at a concentration of 40%. Animals were sacrificed at 3, 6, 9 and 12 months, and the ultrastructure, karyometric indices, and number of synaptic bodies in the pineal gland were analysed. The results showed progressive morphologic alterations in the ethanol-treated animals, which culminated in fatty degeneration of the pineal parenchyma after 6 months. The karyometric indices decreased in both the central and peripheral areas compared with the control …

0301 basic medicineMalemedicine.medical_specialtyPeriod (gene)BiologyPineal ParenchymaPineal Gland03 medical and health sciencesPineal gland0302 clinical medicineMicroscopy Electron TransmissionInternal medicinemedicineAnimalsCircadian rhythmRats WistarEthanolCentral Nervous System DepressantsCell BiologyGeneral MedicineChronic alcoholCircadian RhythmRats030104 developmental biologymedicine.anatomical_structureEndocrinologyUltrastructure030217 neurology & neurosurgeryDevelopmental BiologyTissuecell
researchProduct

Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions

2016

To gain some specific insight into the roles microorganisms might play in non-alcoholic fatty liver disease (NAFLD), some intestinal and lactic acid bacteria and one yeast (Anaerostipes caccae, Bacteroides thetaiotaomicron, Bifidobacterium longum, Enterococcus fecalis, Escherichia coli, Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus plantarum, Weissella confusa, Saccharomyces cerevisiae) were characterized by high performance liquid chromatography for production of ethanol when grown on different carbohydrates: hexoses (glucose and fructose), pentoses (arabinose and ribose), disaccharides (lactose and lactulose), and inulin. Highest amounts of ethanol were produced by S. …

0301 basic medicineMicrobiology (medical)Bifidobacterium longumfecal slurriesLactobacillus fermentum030106 microbiologylcsh:QR1-502Weissella confusaBiologydigestive systemMicrobiologylcsh:Microbiologyfructose03 medical and health scienceschemistry.chemical_compoundfluids and secretionsLactobacillus acidophilusEthanol fuelarabinoseOriginal Researchinulinnon-alcoholic fatty liver diseasefood and beveragesFructosebiology.organism_classificationLactic acid030104 developmental biologyBiochemistrychemistrylactuloseFermentationethanolLactobacillus plantarumFrontiers in Microbiology
researchProduct

2017

Previous studies reported that the use of Metschnikowia pulcherrima in sequential culture fermentation with Saccharomyces cerevisiae mainly induced a reduction of volatile acidity in wine. The impact of the presence of this yeast on the metabolic pathway involved in pyruvate dehydrogenase (PDH) bypass and glycerol production in S. cerevisiae has never been investigated. In this work, we compared acetic acid and glycerol production kinetics between pure S. cerevisiae culture and its sequential culture with M. pulcherrima during alcoholic fermentation. In parallel, the expression levels of the principal genes involved in PDH bypass and glyceropyruvic fermentation in S. cerevisiae were investi…

0301 basic medicineMicrobiology (medical)Fermentation in winemaking030106 microbiologyfood and beveragesBiologyEthanol fermentationbiology.organism_classificationPyruvate dehydrogenase complexMicrobiologyYeast03 medical and health sciencesBiochemistrybiology.proteinFermentationPyruvate decarboxylaseMetschnikowia pulcherrimaAlcohol dehydrogenaseFrontiers in Microbiology
researchProduct

Persistence of Two Non-Saccharomyces Yeasts (Hanseniaspora and Starmerella) in the Cellar

2016

International audience; Different genera and/or species of yeasts present on grape berries, in musts and wines are widely described. Nevertheless, the community of non-Saccharomyces yeasts present in the cellar is still given little attention. Thus it is not known if the cellar is a real ecological niche for these yeasts or if it is merely a transient habitat for populations brought in by grape berries during the winemaking period. This study focused on three species of non-Saccharomyces yeasts commonly encountered during vinification: Starmerella bacillaris (synonymy with Candida zemplinina), Hanseniaspora guilliermondii and Hanseniaspora uvarum. More than 1200 isolates were identified at …

0301 basic medicineMicrobiology (medical)Grape berriesCerevisiaeWine yeast[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition030106 microbiologyStarmerellalcsh:QR1-502StrainsCandida-stellataHanseniasporaMicrobiologySaccharomyceslcsh:MicrobiologyHanseniaspora03 medical and health sciences[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologycellarBotanyOriginal ResearchWinemakingDiversitybiologyfungifood and beveragespersistenceEnological propertiesbiology.organism_classificationSulfur-dioxideYeastCandida zemplininaYeast in winemaking[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitologynon-Saccharomyces strainsStarmerellaHanseniaspora guilliermondiiAlcoholic fermentationPopulation-dynamicsFrontiers in Microbiology
researchProduct

Use of autochthonous yeasts and bacteria in order to control Brettanomyces bruxellensis in wine

2017

Biocontrol strategies for the limitation of undesired microbial developments in foods and beverages represent a keystone toward the goal of more sustainable food systems. Brettanomyces bruxellensis is a wine spoilage microorganism that produces several compounds that are detrimental for the organoleptic quality of the wine, including some classes of volatile phenols. To control the proliferation of this yeast, sulfur dioxide is commonly employed, but the efficiency of this compound depends on the B. bruxellensis strain; and it is subject to wine composition and may induce the entrance in a viable, but nonculturable state of yeasts. Moreover, it can also elicit allergic reactions in humans. …

0301 basic medicineMicroorganism030106 microbiologyFood spoilageVolatile phenolsBrettanomyces bruxellensisWineSaccharomyces cerevisiaePlant ScienceBiochemistry Genetics and Molecular Biology (miscellaneous)Aliments Microbiologia03 medical and health sciencesMalolactic fermentationFood scienceNon- SaccharomycesOenologyOenococcus oeniWinelcsh:TP500-660non-Saccharomycesbiology<i>Brettanomyces bruxellensis</i>; volatile phenols; biocontrol; <i>Saccharomyces cerevisiae</i>; non-<i>Saccharomyces</i>; <i>Oenococcus oeni</i>; wineBiocontrolfood and beverageslcsh:Fermentation industries. Beverages. Alcoholbiology.organism_classificationYeastBrettanomyces bruxellensisViniculturaBiocontrol; Brettanomyces bruxellensis; Non- Saccharomyces; Oenococcus oeni; Saccharomyces cerevisiae; Volatile phenols; WineOenococcus oeniSettore AGR/16 - Microbiologia AgrariaFood Science
researchProduct

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

2021

Background &amp; Aims: Hepatocellular carcinoma (HCC) risk stratification in individuals with dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic fatty liver disease (NAFLD). We aimed to exploit robust polygenic risk scores (PRS) that can be evaluated in the clinic to gain insight into the causal relationship between NAFLD and HCC, and to improve HCC risk stratification. Methods: We examined at-risk individuals (NAFLD cohort, n = 2,566; 226 with HCC; and a replication cohort of 427 German patients with NAFLD) and the general population (UK Biobank [UKBB] cohort, n = 364,048; 202 with HCC). Variants in PNPLA3-TM6SF2-GCKR-MBOAT7 were combined in a hepatic …

0301 basic medicineOncologyLiver CirrhosisMaleMultifactorial InheritanceCirrhosis0302 clinical medicineRisk FactorsNon-alcoholic Fatty Liver DiseaseHepatic fatAdiposityeducation.field_of_studyFatty liverLiver NeoplasmsMiddle AgedPrognosisEuropeCirrhosisLiverCohort030211 gastroenterology & hepatologyBiomarker; Cirrhosis; Genetics; Hepatic fat; Non-alcoholic fatty liver diseaseFemaleLiver cancerCohort studymedicine.medical_specialtyCarcinoma HepatocellularSettore MED/12 - GASTROENTEROLOGIAPopulationRisk Assessment03 medical and health sciencesBiomarker Cirrhosis Genetics Hepatic fat Non-alcoholic fatty liver disease Cross-Sectional Studies Europe Female Genetic Predisposition to Disease Humans Liver Liver Cirrhosis Male Mediation Analysis Middle Aged Multifactorial Inheritance Predictive Value of Tests Prognosis Risk Assessment Risk Factors Adiposity Carcinoma Hepatocellular Non-alcoholic Fatty Liver DiseaseGeneticPredictive Value of TestsInternal medicinemedicineGenetic predispositionGeneticsHumansGenetic Predisposition to DiseaseeducationCirrhosiMediation AnalysisHepatologybusiness.industryCarcinomaCase-control studyHepatocellularBiomarkermedicine.diseasedigestive system diseases030104 developmental biologyCross-Sectional StudiesbusinessJournal of Hepatology
researchProduct

A "systems medicine" approach to the study of non-alcoholic fatty liver disease

2016

a b s t r a c t The prevalence of fatty liver (steatosis) in the general population is rapidly increasing worldwide. The progress of knowledge in the physiopathology of fatty liver is based on the systems biology approach to studying the complex interactions among different physiological systems. Similarly, translational and clinical research should address the complex interplay between these systems impacting on fatty liver. The clinical needs drive the applications of systems medicine to re-define clinical phenotypes, assessing the multiple nature of disease susceptibility and progression (e.g. the definition of risk, prognosis, diag- nosis criteria, and new endpoints of clinical trials).…

0301 basic medicinePathologymedicine.medical_specialtyFatty liver; Medicine; NAFLD; NASH; Personalized; Systems medicine; Gastroenterology; HepatologySystems AnalysisSystems biologyPersonalizedPopulationDiseaseBioinformatics03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineFatty liverNAFLDFatty liver; Medicine; NAFLD; NASH; Personalized; Systems medicinemedicineHumansFatty liver; Medicine; NAFLD; NASH; Personalized; Systems medicine; Hepatology; GastroenterologyeducationFatty liver; Medicine; NAFLD; NASH; Personalized; Systems medicine; Disease Progression; Humans; Non-alcoholic Fatty Liver Disease; Phenotype; Risk Factors; Systems Biology; Systems Analysis; Medicine (all); Hepatology; Gastroenterologyeducation.field_of_studyHepatologybusiness.industrySystems BiologySettore MED/09 - MEDICINA INTERNAFatty liverGastroenterologyNASHHepatologymedicine.diseaseSystems medicineClinical trial030104 developmental biologyPhenotypeSystems medicineDisease ProgressionMedicine030211 gastroenterology & hepatologySteatosisbusiness
researchProduct

A survey of clearing techniques for 3D imaging of tissues with special reference to connective tissue

2016

AbstractFor 3-dimensional (3D) imaging of a tissue, 3 methodological steps are essential and their successful application depends on specific characteristics of the type of tissue. The steps are 1° clearing of the opaque tissue to render it transparent for microscopy, 2° fluorescence labeling of the tissues and 3° 3D imaging. In the past decades, new methodologies were introduced for the clearing steps with their specific advantages and disadvantages. Most clearing techniques have been applied to the central nervous system and other organs that contain relatively low amounts of connective tissue including extracellular matrix. However, tissues that contain large amounts of extracellular mat…

0301 basic medicinePathologymedicine.medical_specialtyTissue FixationHistologyClinical BiochemistryGingiva3D histochemistryConnective tissueBenzoatesSpecimen HandlingExtracellular matrixFixatives03 medical and health sciencesImaging Three-DimensionalDermis3D imagingmedicineClearingAnimalsHumansSkinFluorescent DyesMicroscopy ConfocalStaining and LabelingLight-sheet microscopyHistocytochemistryChemistryPhenyl EthersPhenyl EthersExtracellular matrixCell Biology030104 developmental biologymedicine.anatomical_structureConnective TissueLight sheet fluorescence microscopyClearingBenzyl AlcoholProgress in Histochemistry and Cytochemistry
researchProduct

The Effects of N-Acetylcysteine on the Rat Mesocorticolimbic Pathway: Role of mGluR5 Receptors and Interaction with Ethanol

2021

N-acetylcysteine (NAC) is a prodrug that is marketed as a mucolytic agent and used for the treatment of acetaminophen overdose. Over the last few decades, evidence has been gathered that suggests the potential use of NAC as a new pharmacotherapy for alcohol use disorder (AUD), although its mechanism of action is already being debated. In this paper, we set out to assess both the potential involvement of the glutamate metabotropic receptors (mGluR) in the possible dual effect of NAC administered at two different doses and NAC’s effect on ethanol-induced activation. To this aim, 30 or 120 mg/kg of NAC was intraperitoneally administered to rats with the presence or absence of the negative allo…

0301 basic medicinePharmaceutical ScienceglutamatePharmacologyAcetylcysteine03 medical and health sciencesPharmacy and materia medica0302 clinical medicineNeurochemicalDrug Discoverymental disordersmedicinealcoholismMetabotropic glutamate receptor 5ChemistryCommunicationRGlutamate receptor<i>N</i>-acetylcysteineN-acetylcysteineRS1-441030104 developmental biologyMetabotropic receptorMTEPMechanism of actionMetabotropic glutamate receptorAlcoholismeMedicineMolecular Medicinemedicine.symptomTecnologia farmacèuticaMedicaments030217 neurology & neurosurgerymedicine.drugPharmaceuticals
researchProduct